Pfizer Loses Bid To Limit Damages In Lyrica Suit
A judge refused a Pfizer subsidiary's bid on Thursday to limit the damages it may have to pay for losses stemming from threats the pharma giant made over an epilepsy drug patent,...To view the full article, register now.
Already a subscriber? Click here to view full article